Literature DB >> 7517953

Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.

W M Johnson1, S D Tyler, K R Rozee.   

Abstract

Multilocus enzyme electrophoresis and ribotyping were used to characterize 83 strains of Pseudomonas cepacia, mostly isolated from cystic fibrosis (CF) patients, although a number of isolates from non-CF nosocomial infections and reference environmental strains were represented. Twenty enzyme electrophoretic types (ETs) were determined; of these, one clone (ET12) was associated with six of nine ribotypes (RTs) said to be geographically representative of the United Kingdom and all of the Ontario (Canada) isolates from CF patients. This clone was not associated with nosocomial infections or environmental strains and was never found in CF isolates from British Columbia or Nova Scotia, Canada, or a center in the eastern United States. Individual isolate EcoRI RT signatures did not cluster geographically as did the ET signatures by clonal analysis. Frequently RTs occurred in more than a single ET. Known point source focal nosocomial outbreaks were typified by single ETs and stable RTs. Dendrographic analysis of the strains grouped those strains from CF patients, nosocomial outbreaks, and environmental sources into separate ET families, and diversity analysis indicated that, with the exception of ET17, CF isolates clustered in unique and closely related ETs different from those from nosocomial and environmental sources. This study has also shown the potential of multilocus enzyme electrophoresis to monitor the intercontinental spread of P. cepacia strains in CF patients, and this may have a significant impact on plans for CF patient summer camps and design of infection control practices. Whether the intercontinental ET12 clone, which predominates in the United Kingdom and the province of Ontario, linked by summer camp acquisition, has increased virulence for CF patients remains to be established.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517953      PMCID: PMC263164          DOI: 10.1128/jcm.32.4.924-930.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Pseudomonas cepacia infection in cystic fibrosis.

Authors:  D L Smith; E G Smith; L B Gumery; D E Stableforth
Journal:  Lancet       Date:  1992-01-25       Impact factor: 79.321

2.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

Review 3.  Population genetics of pathogenic bacteria.

Authors:  R K Selander; J M Musser; D A Caugant; M N Gilmour; T S Whittam
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

4.  Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

Authors:  C S Rabkin; W R Jarvis; R L Anderson; J Govan; J Klinger; J LiPuma; W J Martone; H Monteil; C Richard; S Shigeta
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis.

Authors:  E Denamur; B Picard; P Goullet; E Bingen; N Lambert; J Elion
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

6.  rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis.

Authors:  G Martinetti; M Altwegg
Journal:  Res Microbiol       Date:  1990 Nov-Dec       Impact factor: 3.992

7.  Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.

Authors:  E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

8.  Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.

Authors:  L O Lewin; P J Byard; P B Davis
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

9.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

10.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

View more
  57 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.

Authors:  Maria G Detsika; John E Corkill; Marcelo Magalhães; Kerry J Glendinning; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

4.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

5.  Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia.

Authors:  Amanda S Engledow; Enrique G Medrano; Eshwar Mahenthiralingam; John J LiPuma; Carlos F Gonzalez
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

6.  Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson
Journal:  Can J Infect Dis       Date:  1994-03

7.  Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

Authors:  J E Hughes; J Stewart; G R Barclay; J R Govan
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

8.  Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Authors:  Laurent Poirel; José-Manuel Rodriguez-Martinez; Patrick Plésiat; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

9.  Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells.

Authors:  T Mullen; K Markey; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

10.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.